Meaningful Use with MCRS

Providers are able to electronically report cancers to the Minnesota Cancer Reporting System (MCRS) through Meaningful Use (MU) Stage 2, Modified Stage 2, and Stage 3 cancer reporting. Participation in MU cancer reporting is voluntary and only supplements existing cancer reporting sources. MU does not replace existing cancer reporting mechanisms from hospital-based cancer registries and pathology laboratories.

Providers must meet the following criteria:

• Are eligible professionals (EP); hospital-based EPs do not qualify.
• Diagnose or treat patients with reportable cancers.
• Must have reporting technology that is certified under the 2014 Certified Electronic Health Record Technology (CERHT) or under the 2015 CEHRT (see Technical Requirements).
  

Related Information

For more information about Meaningful Use at the Minnesota Department of Health (MDH), including the Declaration of Readiness, steps required to achieve electronic data submission and data transport options:

• Please review Public Health Reporting & Meaningful Use page.

For instructions on registering for electronic MU Cancer Reporting and how to register an individual provider or multiple providers see:

• See the Registration for Electronic Data Exchange page.

How to Register for MU Electronic Submission

Steps to register on the MDH Electronic Data Registry:

1. Create an electronic data registry account.
2. After you submit your registration, a confirmation message will be emailed to the MU contact listed in the registration. Keep this confirmation message as part of your MU documentation for attestation and/or audit.
3. MCRS staff will email the MU contact to collect additional information and place your facility in the onboarding queue.

Technical Requirements

MU Stage 2 option

MCRS accepts cancer reports according to the MU Stage 2 option of physician cancer reporting. This uses the 2014 CEHRT standards and requires data transmissions conforming to the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries, HL7 Clinical Document Architecture (CDA), August 2012. These reports will be accepted under Measure 3, “Specialized Registry Reporting for Modified Stage 2 Meaningful Use” rules.

For more information and to download the 2012 version of the Implementation Guide, please see the Centers for Disease Control and Prevention PHIN Guides page.

MU Stage 3, Measure 4

MCRS also accepts data for MU Stage 3, Measure 4, Public Health Registry Reporting. Reporting technology must be certified under the 2015 Edition CEHRT standard. The actual reports transmitted must conform to HL7 CDA® Release 2 Implementation Guide: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, Release 1; DSTU Release 1.1, U.S. Realm, April 2015.

For more information and to download the Release 2 Implementation Guide, please see the Centers for Disease Control and Prevention PHIN Guides page.

Software for MU Cancer Reporting requires additional certification criteria

• For the 2014 Edition CEHRT, Cancer Case Reporting § 170.314 (f)(5) AND Transmission to Cancer Registries § 170.314 (f)(6) are required.
• For 2015 Edition CEHRT, Transmission to Cancer Registries § 170.315 (f)(4) is required.
• To determine if your electronic health record is certified for MU Cancer Reporting, check the certified health IT product list page.
  

Top of Page